Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Vis graf over relationer

Expertise

Intestinal failure; Short bowel syndrome; Malabsorption; Macro- and Micro-nutrient absorption; Home Parenteral Nutrition; Parenteral Support; IF Epidemiology; HPN complications; Catheter Related Bloodstream Infections; Central Venous Thrombosis; Intestinal Failure Associated Liver Disease; Medical Treatment: Anti-diarrhoeals, Anti-secretory agents; Intestinal Growth Factors; Glucagon-like peptide 1 and 2. Peptide YY, FGF19; Gut-liver axis; Metabolic balance studies; Inflammatory bowel disease

Primære forskningsområder

Intestinal failure; Short bowel syndrome; Malabsorption; Macro- and Micro-nutrient absorption; Home Parenteral Nutrition; Parenteral Support; IF Epidemiology; HPN complications; Catheter Related Bloodstream Infections; Central Venous Thrombosis; Intestinal Failure Associated Liver Disease; Medical Treatment: Anti-diarrhoeals, Anti-secretory agents; Intestinal Growth Factors; Glucagon-like peptide 1 and 2. Peptide YY, FGF19; Gut-liver axis;Metabolic balance studies; Inflammatory bowel disease

Aktuel forskning

Intestinal failure; Short bowel syndrome; Malabsorption; Macro- and Micro-nutrient absorption; Home Parenteral Nutrition; Parenteral Support; IF Epidemiology; HPN complications; Catheter Related Bloodstream Infections; Central Venous Thrombosis; Intestinal Failure Associated Liver Disease; Medical Treatment: Anti-diarrhoeals, Anti-secretory agents; Intestinal Growth Factors; Glucagon-like peptide 1 and 2. Peptide YY, FGF19; Gut-liver axis;Metabolic balance studies; Inflammatory bowel disease

Mulige interessekonflikter

Grants/ research support from the Novo Nordic Foundation; honoraria or consultation fees from NPS Pharma, Shire, Ferring, Baxter, Fresenius Kabi, Zealand Pharma, Naia Pharma and the Aguettant Institute.

ID: 33010